Passage Bio Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Passage Bio Inc
TickerPASG
CIK #0001787297
CUSIP702712100
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
AddressTwo Commerce Square 2001 Market Street, 28th Floor, Philadelphia, PA 19103
Source [EDGAR]
CIK Filing 2011 - 2024
[0001787297] 10-K
[0001787297] 10-Q
[0001787297] 3
[0001787297] 4
[0001787297] 8-K
[0001787297] D
[0001787297] SC 13D
[0001787297] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Lynx1 Capital Management LP Passage Bio Inc [2022-09-29] 5.1
BlackRock Inc Passage Bio Inc [2022-07-08] 2.5
BlackRock Inc Passage Bio Inc [2022-02-04] 6.5
Deep Track Capital LP Passage Bio Inc [2021-10-25] 5.27
New Leaf Ventures III LP Passage Bio Inc [2021-02-11] 4.7
LAV Prescience Ltd Passage Bio Inc [2021-02-09] 5.3
FMR LLC Passage Bio Inc [2020-06-10] 0.0
Versant Venture Capital VI LP Passage Bio Inc [2020-03-13] 11.0
Access Industries Holdings LLC Passage Bio Inc [2020-03-12] 5.9
Frazier Life Sciences IX LP Passage Bio Inc [2020-03-09] 10.9
OrbiMed Advisors LLC Passage Bio Inc [2020-03-09] 13.5
Vivo Capital VIII LLC Passage Bio Inc [2020-03-06] 4.9
Form 3/4/5 Filer 2011 - 2024
Passage BIO, Inc.
Kamarck Michael E.
Countouriotis Athena
Gowen Maxine
Islam Saqib
Woiwode Thomas
Porter Derrell
Kapadia Sandip
King Simona
Fotopoulos Alexandros
Cale Edgar B.
Forman Mark S
Chou William
Toernsen Monika Maria
Goldsmith Bruce A
OrbiMed Advisors LLC
OrbiMed Capital GP VII LLC
Salinas Eliseo Oreste
Quigley Jill M.
Burkavage Brian
Yamada Tadataka
Ratcliffe Liam
Morris Richard Steven
Romano Gary
Versant Ventures VI GP-GP, LLC
Versant Venture Capital VI, L.P.
Versant Vantage I GP, L.P.
Versant Vantage I GP-GP, LLC
Versant Ventures VI GP, L.P.
Versant Vantage I, L.P.
Topper James N
Fhmls IX LLC
Fhmls IX LP
Frazier Life Sciences IX, L.P.
Heron Patrick J
Squinto Stephen P
Form 13F Holdings
Firm Period DFND Voting Shares
OrbiMed Advisors LLC [2023-03-31] DFND 6,841,423.0 8,931,999.0
Versant Venture Management LLC [2023-03-31] OTR 0.0 4,959,769.0
Frazier Life Sciences Management LP [2023-03-31] SOLE 3,756,915.0 3,756,915.0
Lynx1 Capital Management LP [2023-03-31] OTR 0.0 3,407,598.0
New Leaf Venture Partners LLC [2023-03-31] DFND 2,497,922.0 2,497,922.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 2,005,131.0
BlackRock Inc. [2023-03-31] SOLE 974,674.0 1,053,999.0
Renaissance Technologies LLC [2023-03-31] SOLE 460,600.0 964,900.0
Newtyn Management LLC [2023-03-31] SOLE 665,221.0 665,221.0
JPMorgan Chase & Co [2023-03-31] DFND 589,008.0 589,008.0
Acadian Asset Management LLC [2023-03-31] DFND 578,806.0 578,806.0
Bridgeway Capital Management LLC [2023-03-31] SOLE 389,600.0 389,600.0
Weiss Multi-Strategy Advisers LLC [2023-03-31] SOLE 367,696.0 367,696.0
BML Capital Management LLC [2023-03-31] SOLE 0.0 337,467.0
Geode Capital Management LLC [2023-03-31] DFND 331,914.0 331,914.0
Two Sigma Advisers LP [2023-03-31] SOLE 280,700.0 310,500.0
Tang Capital Management LLC [2023-03-31] OTR 0.0 300,000.0
Millennium Management LLC [2023-03-31] SOLE 298,090.0 298,090.0
Two Sigma Investments LP [2023-03-31] SOLE 288,926.0 288,926.0
D. E. Shaw & Co., Inc. [2023-03-31] DFND 274,335.0 274,335.0
Morgan Stanley [2023-03-31] DFND 269,872.0 271,172.0
GSA Capital Partners LLP [2023-03-31] SOLE 130,188.0 130,188.0
State Street Corp [2023-03-31] DFND 123,873.0 123,873.0
Fiduciary Trust Co [2023-03-31] SOLE 115,000.0 115,000.0
RBF Capital, LLC [2023-03-31] SOLE 110,807.0 110,807.0
Cornercap Investment Counsel Inc [2023-03-31] SOLE 69,006.0 101,488.0
Marquette Asset Management LLC [2023-03-31] SOLE 0.0 86,050.0
Connor Clark & Lunn Investment Management Ltd [2023-03-31] SOLE 82,895.0 82,895.0
Vontobel Holding Ltd. [2023-03-31] DFND 0.0 80,000.0
Citadel Advisors LLC [2023-03-31] DFND 64,378.0 64,378.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com